Valuation: Biogen Inc.

Market Cap 37.34B 33.51B 30.95B 28.06B 52.45B 3,547B 53.09B 371B 147B 1,859B 140B 137B 5,896B P/E 2026 *
43.3x
P/E 2027 * 22.7x
Enterprise Value 42.29B 37.95B 35.04B 31.78B 59.39B 4,017B 60.12B 420B 167B 2,105B 159B 155B 6,676B EV / Sales 2026 *
4.05x
EV / Sales 2027 * 3.73x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.05%
1 week+4.12%
Current month+11.08%
1 month+9.71%
3 months+22.03%
6 months+36.82%
Current year+42.56%
1 week 240.02
Extreme 240.02
258.78
1 month 215.73
Extreme 215.73
258.78
Current year 160.36
Extreme 160.3645
258.78
1 year 138
Extreme 138
258.78
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2024-10-27
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/26 Exercice

Controller/Auditor

62 0.0000%
9/1/26 Free

General Counsel

7,405 0.0050%
8/4/26 Sell

Director

-593 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%+4.12%+68.24%+5.77% 37.34B
+1.29%+1.77%+57.69%+128.60% 1,143B
+1.46%+5.39%+45.33%+84.77% 647B
+0.68%+1.07%+26.50%+102.86% 506B
+0.21%+1.73%+52.74%+65.27% 384B
-0.09%-5.40%+62.91%+38.08% 350B
+1.38%+2.63%+31.71%+53.87% 293B
+0.59%+2.01%+3.73%+25.94% 265B
+1.35%+3.26%+54.96%+71.97% 242B
+0.78%+4.28%+35.86%+105.93% 197B
Average +0.65%+1.16%+43.97%+68.31% 406.49B
Weighted average by Cap. +0.93%+0.74%+45.31%+86.96%

Financials

2026 *2027 *
Net sales 10.45B 9.38B 8.66B 7.85B 14.68B 992B 14.86B 104B 41.23B 520B 39.22B 38.38B 1,650B 10.66B 9.56B 8.83B 8.01B 14.97B 1,012B 15.15B 106B 42.05B 531B 40B 39.14B 1,682B
Net income 942M 845M 781M 708M 1.32B 89.46B 1.34B 9.36B 3.72B 46.89B 3.54B 3.46B 149B 1.84B 1.65B 1.52B 1.38B 2.58B 175B 2.61B 18.26B 7.25B 91.51B 6.9B 6.75B 290B
Net Debt 4.94B 4.44B 4.1B 3.72B 6.95B 470B 7.03B 49.13B 19.51B 246B 18.56B 18.16B 781B 2.4B 2.15B 1.99B 1.8B 3.37B 228B 3.41B 23.81B 9.46B 119B 9B 8.8B 378B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
26-10-28 $250.65 -0.82% 588,946
26-10-27 $252.73 +0.19% 1,393,391
26-10-26 $252.26 +0.63% 958,847
26-10-23 $250.69 -1.24% 1,157,376
26-10-22 $253.84 +5.34% 2,237,991
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
252.73USD
Average target price
248.26USD
Spread / Average Target
-1.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biogen Inc.
  1. Stock Market
  2. Stocks
  3. BIIB Stock